Article By:
The Fly
Wednesday, September 14, 2016 2:53 PM EDT
Takeda Pharmaceutical, Japan's largest drugmaker, is reportedly setting aside up to $20B as it hunts for acquisitions in the U.S.
In this article: AGN, TKPYY Also: SGYP, VTAE, ALPMY, ACAD, ARIA, SGEN, EXEL, EVOK, BLUE, TBPH, ADMS, VRX
